Synopsis of the PI-RADS V2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use

Overview

Journal Eur Urol

Specialty Urology

Date 2015 Sep 12

PMID 26361169

Citations 198

Authors

Jelle O Barentsz

Jeffrey C Weinreb

Sadhna Verma

Harriet C Thoeny

Clare M Tempany

Faina Shtern

Anwar R Padhani

Daniel Margolis

Katarzyna J Macura

Masoom A Haider

Francois Cornud

Peter L Choyke

Affiliations

Soon will be listed here.

Citing Articles

Percutaneous Magnetic Resonance Imaging-Guided Focal Laser Ablation (MRI-FLA) of Prostate Tumors: A Systematic Review and Network Meta-Analysis.

Marcelin C, Klein C, Robert G, Bladou F, Grenier N, Jambon E J Pers Med. 2024; 14(12).

PMID: 39728059 PMC: 11678844. DOI: 10.3390/jpm14121146.

Feasibility of quantitative relaxometry for prostate target localization and response assessment in magnetic resonance-guided online adaptive stereotactic body radiotherapy.

Subashi E, LoCastro E, Burleson S, Apte A, Zelefsky M, Tyagi N Phys Imaging Radiat Oncol. 2024; 32():100678.

PMID: 39717186 PMC: 11665667. DOI: 10.1016/j.phro.2024.100678.

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer.

Hamm C, Asbach P, Pohlmann A, Schoots I, Kasivisvanathan V, Henkel T JAMA Oncol. 2024; 11(2):145-153.

PMID: 39666360 PMC: 11843366. DOI: 10.1001/jamaoncol.2024.5497.

Focal therapy using high-intensity focused ultrasound with intraoperative prostate compression for patients with localized prostate cancer: a multi-center prospective study with 7 year experience.

Shoji S, Naruse J, Ohno S, Aoki M, Takahashi K, Yuzuriha S Prostate Cancer Prostatic Dis. 2024; .

PMID: 39580599 DOI: 10.1038/s41391-024-00921-0.

Quantitative magnetic resonance imaging in prostate cancer: A review of current technology.

Dhiman A, Kumar V, Das C World J Radiol. 2024; 16(10):497-511.

PMID: 39494137 PMC: 11525833. DOI: 10.4329/wjr.v16.i10.497.

References

Padhani A, Liu G, Koh D, Chenevert T, Thoeny H, Takahara T . Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009; 11(2):102-25. PMC: 2631136. DOI: 10.1593/neo.81328. View

Wolters T, Roobol M, van Leeuwen P, van den Bergh R, Hoedemaeker R, van Leenders G . A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol. 2010; 185(1):121-5. DOI: 10.1016/j.juro.2010.08.082. View

Dickinson L, Ahmed H, Allen C, Barentsz J, Carey B, Futterer J . Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol. 2011; 59(4):477-94. DOI: 10.1016/j.eururo.2010.12.009. View

Heidenreich A . Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol. 2011; 59(4):495-7. DOI: 10.1016/j.eururo.2011.01.013. View

Barentsz J, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G . ESUR prostate MR guidelines 2012. Eur Radiol. 2012; 22(4):746-57. PMC: 3297750. DOI: 10.1007/s00330-011-2377-y. View

Portalez D, Mozer P, Cornud F, Renard-Penna R, Misrai V, Thoulouzan M . Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol. 2012; 62(6):986-96. DOI: 10.1016/j.eururo.2012.06.044. View

Barry Delongchamps N, Peyromaure M, Schull A, Beuvon F, Bouazza N, Flam T . Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol. 2012; 189(2):493-9. DOI: 10.1016/j.juro.2012.08.195. View

Arumainayagam N, Ahmed H, Moore C, Freeman A, Allen C, Sohaib S . Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. Radiology. 2013; 268(3):761-9. DOI: 10.1148/radiol.13120641. View

Abd-Alazeez M, Ahmed H, Arya M, Charman S, Anastasiadis E, Freeman A . The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?. Urol Oncol. 2013; 32(1):45.e17-22. PMC: 4082533. DOI: 10.1016/j.urolonc.2013.06.007. View

10.

Abd-Alazeez M, Kirkham A, Ahmed H, Arya M, Anastasiadis E, Charman S . Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard. Prostate Cancer Prostatic Dis. 2013; 17(1):40-6. PMC: 3954968. DOI: 10.1038/pcan.2013.43. View

11.

Pokorny M, de Rooij M, Duncan E, Schroder F, Parkinson R, Barentsz J . Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol. 2014; 66(1):22-9. DOI: 10.1016/j.eururo.2014.03.002. View

12.

Vache T, Bratan F, Mege-Lechevallier F, Roche S, Rabilloud M, Rouviere O . Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. Radiology. 2014; 272(2):446-55. DOI: 10.1148/radiol.14131584. View

13.

Radtke J, Kuru T, Boxler S, Alt C, Popeneciu I, Huettenbrink C . Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. J Urol. 2014; 193(1):87-94. DOI: 10.1016/j.juro.2014.07.098. View

14.

Panebianco V, Barchetti F, Sciarra A, Ciardi A, Indino E, Papalia R . Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol. 2014; 33(1):17.e1-17.e7. DOI: 10.1016/j.urolonc.2014.09.013. View

15.

Barry Delongchamps N, Lefevre A, Bouazza N, Beuvon F, Legman P, Cornud F . Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?. J Urol. 2014; 193(4):1198-204. DOI: 10.1016/j.juro.2014.11.002. View

16.

Hamoen E, de Rooij M, Witjes J, Barentsz J, Rovers M . Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. Eur Urol. 2014; 67(6):1112-1121. DOI: 10.1016/j.eururo.2014.10.033. View

17.

Schoots I, Roobol M, Nieboer D, Bangma C, Steyerberg E, Hunink M . Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol. 2014; 68(3):438-50. DOI: 10.1016/j.eururo.2014.11.037. View

18.

Renard-Penna R, Mozer P, Cornud F, Barry-Delongchamps N, Bruguiere E, Portalez D . Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy. Radiology. 2015; 275(2):458-68. DOI: 10.1148/radiol.14140184. View

19.

Siddiqui M, Rais-Bahrami S, Turkbey B, George A, Rothwax J, Shakir N . Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA. 2015; 313(4):390-7. PMC: 4572575. DOI: 10.1001/jama.2014.17942. View

20.

Futterer J, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A . Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. Eur Urol. 2015; 68(6):1045-53. DOI: 10.1016/j.eururo.2015.01.013. View